Vaccinations and solid-organ transplantation: Review and recommendations;Vacunaciones y trasplante de órgano sólido: Revisión y recomendaciones

Anales de Pediatria

Volumn 58, Issue 4, 2003, Pages 364-375

  Iglesias Berengue, J ^a   Lopez Espinosa J ^a   Campins Marti M ^a   Ortega Lopez J ^a   Moraga Llop, F ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Immunosuppression; Pediatric; Solid organ transplantation; Vaccines

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; TETANUS TOXOID; TRIPLE VACCINE; VIRUS VACCINE;

BACTERIAL INFECTION; CHICKENPOX; DIPHTHERIA; GRAFT REJECTION; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLUENZA; ORGAN TRANSPLANTATION; PEDIATRIC SURGERY; PERTUSSIS; POLIOMYELITIS; RABIES; REVIEW; STREPTOCOCCUS INFECTION; TETANUS; TUBERCULOSIS; VACCINATION; VIRUS INFECTION; ARTICLE; CHILD; IMMUNE DEFICIENCY; IMMUNIZATION; STANDARD;

CHILD; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOCOMPROMISED HOST; ORGAN TRANSPLANTATION; VACCINATION;

EID: 0041657856     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13045245     Document Type: Review

References (95)

1. Jaudes PK, Diamond LJ. Neglect of chronically ill children. Am J Dis Child 1986;140:655-8.
2. Ginsburg CM, Andrews W. Orthotopic hepatic transplantation for unimmunized children: A paradox of contemporary medical care. Pediatric Infect Dis J 1987;6:764-5.
3. Furth SL, Neu AM, Sullivan EK, Gensler G, Tejani A, Fivush BA. Immunization practices in children with renal disease: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997;11:443-6.
4. CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR 2000; 49(n°. RR-10):1-125.
5. De la Cámara R, Bischofberger C, Campins M, Carrearas E. Inmunización postrasplante de progenitores hemopoyéticos: revisión y recomendaciones. Med Clin (Barc) 1998;110:146-56.
6. Comité Asesor de Vacunas de la Asociación Española de Pediatría. Calendario vacunal de la Asociación Española de Pediatría 2003. An Pediatr 2003;58:257-62.
7. Lee N, Kobayashi RH. Immunizations in the immunocompromised host. En: Patrick CC, editor. Infections in Immunocompromised Infants and Children. New York: Churchill Livingstone, 1992; p. 741-7.
8. Kaplan SL. Heart transplants: Infections in immunocompromised infants and children. En: Patrick CC, editor. Infections in Immunocompromised Infants and Children. New York: Churchill Livingstone, 1992; p. 251-60.
9. Hernández T, Matos S. Vacunaciones en niños en situaciones especiales. En: Campins M, Moraga FA, editores. Vacunas 2000. Barcelona: Prous Science, 2000; p. 119-30.
10. Campins M, Batalla J. La vacunación de pacientes que requieren cuidados médicos continuados. En: Rodés J, Carné X, Trilla A, editores. Manual de terapéutica médica. Barcelona: Masson, 2002; p. 1129-34.
11. Stark K, Günther M, Schönfeld C, Tullius SG, Bienzle U. Immunisations in solid-organ transplant recipients. Lancet 2002;359: 957-65.
12. Huzly D, Neifer S, Reinke P, Schröder K, Schönfeld C, Hofmann T, et al. Routine immunizations in adult renal transplant recipients. Transplantation 1997;63:839-45.
13. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000;30:857-69.
14. Gruber WC. Immunizatios in the immunocompromised host. En: Patrick CC, editor. Clinical management of infections in inmunocompromised infants and children. Philadelphia: Lippincott Williams, 2001; p. 511-35.
15. Neu AM, Fivush BA. Recommended immunization practices for pediatric renal tranplant recipients. Pediatr Transplant 1998;2: 263-9.
16. Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, et al. Lack of Transmission of the Live Attenuated Varicella Vaccine Virus to Immunocompromised Children After Immunization of Their Siblings. Pediatrics 1991;87:166-70.
17. Mauch TJ, Bratton S, Myers T, Krane E, Gentry SR, Kashtan CE. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics 1994;94:225-9.
18. Van Thiel DH. Vaccination of patients with liver disease: Who, when, and how. Liver Transpl Surg 1998;4:185-7.
19. a ed. Philadelphia: WB Saunders, 1999; p. 98-110.
20. Welch TR, Balistreri W, Daniels S. Care of the child with a solid organ transplant: What is the role of the generalist? J Pediatr 1997;130:850-1.
21. Kelly DA, Mayer D. Liver Transplantation. En: Kelly DA, editor. Diseases of the liver and Biliary System in Children. Oxford: Blackwell Science, 1999; p. 293-312.
22. Comité Asesor de Vacunas de la Asociación Española de Pediatría. Manual de Vacunas en Pediatría. Madrid: Litofinter, 2001.
23. Mazariegos GV, Green M, Reyes J, Nour B, Tzakis A, Starzl TE. Rubella infection after orthotopic liver transplantation. Pediatr Infect Dis J 1994;13:161-2.
24. Bakshi N, Lawson J, Hanson R, Ames C, Vinters HV. Fatal mumps meningoencephalitis in a child with severe combined immunodeficiency after bone marrow transplantation. J Child Neurol 1996;11:159-62.
25. Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ. Response to measles mumps-rubella vaccine in children on dialysis. Pediatr Nephrol 1992;6:187-9.
26. American Academy of Pediatrics, Committee on Infectious Diseases. Recommended Childhood Immunization Schedule-United States 2002. Pediatrics 2002;109:162-4.
27. Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver trasnplantation. J Pediatr 1993;123:87-9.
28. Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1992;11:1008-14.
29. a ed. Philadelphia: WB Saunders, 1999; p. 222-66.
30. Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001;20:63-75.
31. AAP Committee on Infectious Diseases. Poliomyelitis prevention: Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. Pediatrics 1997;99:330-5.
32. Balloni A, Assael BM, Ghio L, Pedrazzi C, Nebbia G, Gridelli B, et al. Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation. Vaccine 1999;17:2507-11.
33. Kitai IC, King S, Gafni A. An Economic Evaluation of Varicella Vaccine for Pediatric Liver and Kidney Transplant Recipients. Clin Infect Dis 1993;17:441-7.
34. Donati M, Zuckerman M, Dhawan A, Hadzic N, Heaton N, North-Lewis P, et al. Response to varicella immunization in pediatric liver transplant recipients. Transplantation 2000;70: 1401-4.
35. Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation: Long-term results of vaccination. Pediatrics 1997;99:35-9.
36. Nithichaiyo C, Chongsrisawat V, Hutagalung Y, Bock HL, Poovorawa Y. Immunogenicity and adverse effects of live attenuated varicella vaccine (Oka-strain) in children with chronic liver disease. Asian Pac J Allergy Immunol 2001;19:101-5.
37. Giacchino R, Marcellini M, Timitilli A, Degli-Innocenti L, Losurdo G, Palumbo M, et al. Varicella vaccine in children requiring renal or hepatic transplantation. Transplantation 1995;60:1055-6.
38. Pandya A, Wasfy S, Hebert D, Allen UD. Varicella-zoster infection in pediatric solid- organ transplant recipients: A hospital-based study in the prevaricella vaccine era. Pediatr Transplant 2001;5:153-9.
39. Furth SL, Sullivan EK, Neu AM, Tejuni A, Fivush BA. Varicella in the first year after renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Pediatr Transplant 1997;1:37-42.
40. McGregor RS, Zitelli BJ, Urbach AH, Malatack JJ, Gartner JC. Varicella in Pediatric Orthotopic Liver Transplant Recipients. Pediatrics 1989;83:256-61.
41. Feldhoff C, Balfour HH, Simmons RL. Varicella in children with renal transplants. J Pediatr 1981;98:25-31.
42. Zamora I, Simón JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 1994;8:190-2.
43. Santiago-Delpín EA. Varicella after kidney transplantation. Pediatr Transplant 1998;2:244.
44. Furth SL, Fivush BA. Varicella vaccination in pediatric kidney transplant candidates. Pediatr Transplant 2002;6:97-100.
45. Aguado JM, Herrero JA, Gavalda J, Torre-Cisneros J, Blanes M, Ruf G, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997;63:1278-86.
46. Köseoglu F, Emiroglu R, Karakayali H, Bilgin N, Haberal M. Prevalence of Mycobacterial Infection in Solid Organ Transplant Recipients. Transplant Proc 2001;33:1782-4.
47. Muñiz J. Indicaciones de la vacuna BCG en nuestro medio. En: Campins M, Moraga FA, editores. Vacunas 2001. Barcelona: Prous Science, 2001; p. 191-203.
48. CDC issues recommendations on the role of BCG vaccine in the prevention and Control of tuberculosis. Am Fam Physician 1996;54:1115-8.
49. Gilbert DN, Moellering RC, Sande MA. The Sanford Guide to Antimicrobial Therapy 2002 (32ND Edition). Hyde Park: Antimicrobial Therapy, 2002.
50. Mensa J, Gatell JM, Jinénez de Anta MT, Prats G, Domínguez-Gil A. Prevención de las Infecciones. Guía de Terapéutica Antimicrobiana 2002. Madrid: Editores Médicos, 2002; p. 409-48.
51. Moraga Llop FA. Quimioprofilaxis en pediatría. Barcelona: Prous Science, 1996.
52. Ghio L, Pedrazzi C, Assael BM, Panuccio A, Foti M, Edefonti A. Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant. J Pediatr 1997;130: 987-9.
53. Enke BU, Bokenkamp A, Offiner G, Bartmann P, Brodehl J. Response to Diphtheria and tetanus booster vaccination in pediatric renal transplant recipients. Transplantation 1997;64: 237-41.
54. Pedrazzi C, Ghio L, Balloni A, Panuccio, A, Foti M, Edefonti A, et al. Duration of immunity to diphtheria and tetanus in young kidney transplant patients. Pediatr Transplant 1999;3:109-14.
55. Sever MS, Yildiz A, Eraksoy H, Badur S, Yüksel-Önel D, Görcin B, et al. Immune response to Haemophilus influenzae Type b vaccination in renal transplant recipients with well-functioning allografts. Nephron 1999;81:55-9.
56. Neu AM, Lederman HM, Warady BA. Haemophilus influenzae type b immunization in infants on peritoneal dialysis. Pediatric Peritoneal Dialysis Study Consortium. Pediatr Nephrol 1996;10: 84-5.
57. Dengler TJ, Strnad N, Zimmermann R, Allers C, Markus BH, Nessen SV, et al. Pneumococcal vaccination after heart and liver transplantation. Immune responses in immunosuppressed patients and in healthy controls. Dtsch Med Wochenschr 1996;121:1519-25.
58. Campins M, Moraga FA. Vacuna antineumocócica 23-valente. En: Moraga FA, editor. La enfermedad neumocócica en el niño. Barcelona: Prous Science, 2001; p. 87-104.
59. Campins M, Anoro R, Callís L, Pinart N, Cruz MJ, De Gracia J, et al. Inmunogenicidad de la vacuna antineumocócica de 23 polisacáridos en niños con enfermedad renal crónica. An Esp Pediatr 2000;52:220-40.
60. Moraga FA, Campins M, De Juan Martín F. Vacuna conjugada antineumocócica heptavalente. En: Moraga FA, editor. La enfermedad neumocócica en el niño. Barcelona: Prous Science, 2001; p. 105-35.
61. Furth SL, Neu AM, Case M, Lederman HM, Steinhoff M, Fivush B. Pneumococcal polysaccharide vaccine in children with chronic renal disease: A prospective study of antibody response and duration. J Pediatr 1996;128:99-101.
62. Kazoncioglu R, Sever MS, Yüksel-Önel D. Immunization of renal transplant Recipients with pneumococcal polysaccharide vaccine. Clin Transplant 2000;14:61-5.
63. Dengler TJ, Strnad N, Buhring I, Zimmermann R, Girgsdies O, Kubler WE, et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 1998;66:1340-7.
64. Sorensen RU, Leiva LE, Giangrosso PA. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 1998;17:685-91.
65. Moraga FA. Avances en vacunas y enfermedad invasora en el niño. Vacuna neumocócica conjugada heptavalente. Rev Esp Quimioterap 2001;14:319-30.
66. McCashland TM, Preheim LC, Gentry-Nielsen MJ. Pneumococcal Vaccine Response in Cirrhosis and Liver Transplantation. J Infect Dis 2000;181:757-60.
67. Quintini I, Velardi A, Le Moli S. Antibacterial polysaccharide antibody deficiency After allogeneic bone marrow transplantation. J Clin Immunol 1990;10:160-6.
68. Kacsmarski EB. Experiencia en Reino Unido con la vacuna meningocócica C conjugada. En: Campins M, Moraga FA, editores. Vacunas 2001, Barcelona: Prous Science, 2001; p. 17-25.
69. Strak K, Günther M, Neuhaus R, Reinke P, Schröder K, Linnig S, et al. Immunogenicity and Safety of Hepatitis A Vaccine in Liver and Renal Transplant Recipients. J Infect Dis 1999;180:2014-7.
70. Günther M, Stark K, Neuhaus R, Reinke P, Schröder K, Bienzle U. Rapid decline of antiboidies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 2001;71: 477-9.
71. Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001;72:272-6.
72. Jiang H, Kobayashi M. Differences between cyclosporin A and tacrolimus in organ transplantation. Transplant Proc 1999;31:1978.
73. Arslan M, Wiesner RH, Poterucha JJ, Gross JB Jr, Zein NN. Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation. Liver Transplant 2000;6:191-5.
74. Pessoa MG, Terrault NA, Ferrell LD. Hepatitis after liver transplantation: The role of the known and unknown viruses. Liver Transpl Surg 1998;4:461-8.
75. Greenbreg DP, Vadheim CM, Wong VK. Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age. Pediatr Infect Dis J 1996;15:590-6.
76. Duca P, Del Pont JM, D'Agostino D. Successful Immune Response to a Recombinant Hepatitis B Vaccine in Children After Liver Transplantation. J Pediatr Gastroenterol Nutr 2001;32: 168-70.
77. Sokal EM, Ulla L, Otte JB. Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children. Dig Dis Sci 1992;37:1250-2.
78. Van Damme P. Vacuna antihepatitis B. Nuevos adyuvantes y nuevas pautas. En: Campins M, Moraga FA, editores. Vacunas 2001. Barcelona: Prous Science, 2001; p. 181-9.
79. Arlan M, Wiesner RH, Sievers C, Egan K, Zein NN. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transplant 2001;7:314-20.
80. Engler SH, Sauer PW, Golling M, Klar EA, Benz C, Stremmel W, et al. Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol 2001;13:363-7.
81. Kallinowski B, Benz C, Buchholz L, Stremmel W. Accelerated schadule of hepatitis B vaccination in liver transplant candidates. Transplant Proc 1998;30:797-9.
82. Loinaz C, De Juanes JR, González EM. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997;44:235-8.
83. Lykavieris P, Fabre M, Yvart J. HBV infection in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1993;16:321-7.
84. Sánchez-Fueyo A, Rimola A, Grande L. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000;31:496-501.
85. Duchini A, Hendry RM, Redfield DC, Pockros PJ. Influenza infection in patients before and after liver transplantation. Liver Transplant 2000;6:531-42.
86. Furth SL, Seu AM, McColley SA, Case B, Steinhoff M, Fivus B. Immune response to influenza vaccination in children with renal disease. Pediatr Nephrol 1995;9:566-8.
87. Hayden FG. Prevention and treatment of influenza in immuno-compromised patients. Am J Med 1997;102:55-60.
88. Mauch TJ, Crouch NA, Freese DK, Braunlin EA, Dunn DL, Kashtan CE. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 1995;127:957-60.
89. Mack DR, Chartrand SA, Rubby EI, Antonson DL, Shaw BW Jr, Heffron TG. Influenza vaccination following liver transplantation in children. Liver Transpl Surg 1996;2:431-7.
90. Edvarsson V, Flynn J, Deforest A. Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant 1996;10:556-60.
91. Sanchez-Fructuoso AI, Prats D, Naranjo P, Fernández-Pérez C, González MJ, Mariano A, et al. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols. Mycophenolate versus Azathioprine. Transplantation 2000;69: 436-9.
92. Blumberg EA, Albano C, Pruett T. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996;22:295-302.
93. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998;338:1405-12.
94. Moraga Llop FA, Campins Martí M. Importancia de la gripe en el niño. Vacuna antigripal intranasal: ¿otra inmunización sistemática? An Esp Pediatr 2000;53:299-304.
95. Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect Dis Clin North Am 2001;15:273-305.